Currently, there are 205.10M common shares owned by the public and among those 177.25M shares have been available to trade.
The company’s stock has a 5-day price change of 33.42% and 118.74% over the past three months. HIMS shares are trading 262.02% year to date (YTD), with the 12-month market performance up to 269.92% higher. It has a 12-month low price of $8.09 and touched a high of $35.02 over the same period. HIMS has an average intraday trading volume of 14.87 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 30.22%, 48.29%, and 80.52% respectively.
Institutional ownership of Hims & Hers Health Inc (NYSE: HIMS) shares accounts for 56.02% of the company’s 205.10M shares outstanding.
It has a market capitalization of $7.48B and a beta (3y monthly) value of 1.20. The stock’s trailing 12-month PE ratio is 74.53, while the earnings-per-share (ttm) stands at $0.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.65% over the week and 12.48% over the month.
Earnings per share for the fiscal year are expected to increase by 824.74%, and 11.35% over the next financial year.
Needham coverage for the Hims & Hers Health Inc (HIMS) stock in a research note released on August 22, 2024 offered a Buy rating with a price target of $24. Imperial Capital was of a view on August 09, 2024 that the stock is In-line, while Citigroup gave the stock Neutral rating on May 22, 2024, issuing a price target of $16- $20. Jefferies on their part issued Hold rating on April 16, 2024.
